SCHEMBL29369929

SCHEMBL29369929

O=C1c2c(O)cc(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)cc2O[C@H](c2ccc(O)cc2)[C@H]1O

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLCO2B1 O94956 3/20 0.69
▸ PTPN1 P18031 3/20 0.69
▸ SYNJ2 O15056 1/20 0.61
▸ KDM1A O60341 1/20 0.57
▸ CYP19A1 P11511 1/20 0.55
▸ GSK3B P49841 1/20 0.55
▸ UBE2N P61088 1/20 0.55
▸ TYR P14679 2/20 0.55
▸ SMN1; SMN2 Q16637 3/20 0.54
▸ TNF P01375 1/20 0.54
▸ PTGS2 P35354 2/20 0.54
▸ PTGS1 P23219 1/20 0.54
▸ NPC1 O15118 2/20 0.53
▸ RAB9A P51151 2/20 0.53
▸ LMNA P02545 1/20 0.53
▸ HPGD P15428 1/20 0.53
▸ CDK5 Q00535 1/20 0.52
▸ CDK5R1 Q15078 1/20 0.52
▸ TRPA1 O75762 1/20 0.52
▸ P4HB P07237 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27161054 1.00 SLCO2B1 (0.69) SLCO2B1PTPN1SYNJ2KDM1ACYP19A1
SCHEMBL1771703 0.87 PTPN1 (0.54) SLCO2B1PTPN1SYNJ2KDM1ATYR
SCHEMBL3776571 0.85 SLCO2B1 (0.65) SLCO2B1PTPN1SYNJ2LMNAHPGD
SCHEMBL13010127 0.85 SLCO2B1 (0.65) SLCO2B1PTPN1SYNJ2LMNAHPGD
SCHEMBL29625608 0.85 SLCO2B1 (0.65) SLCO2B1PTPN1SYNJ2LMNAHPGD
Prunin SCHEMBL1122487 0.82 SLCO2B1 (1.00) SLCO2B1PTPN1SYNJ2KDM1ACYP19A1
Dihydrogenistin SCHEMBL572117 0.82 SLCO2B1 (0.65) SLCO2B1PTPN1SYNJ2KDM1ACYP19A1
Prunin SCHEMBL318230 0.82 SLCO2B1 (1.00) SLCO2B1PTPN1SYNJ2KDM1ACYP19A1
Prunin SCHEMBL31233345 0.82 SLCO2B1 (1.00) SLCO2B1PTPN1SYNJ2KDM1ACYP19A1
Prunin SCHEMBL318229 0.82 SLCO2B1 (1.00) SLCO2B1PTPN1SYNJ2KDM1ACYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114838724-B Sequence waiting type tracking method 深圳市微视星辰科技有限公司 2025-03-25 — — CN claimed
CN-114838724-A Sequence waiting type tracking method 深圳市微视星辰科技有限公司 2022-08-02 — — CN claimed
EP-4580594-A1 ANTIOXIDANT COMPOSITION COMPRISING 5-DEOXYFLAVONOIDS AnalytiCon Discovery - Zweigniederlassung der BRAIN Biotech AG (DE) 2025-07-09 — — EP disclosed
CN-114838724-B Sequence waiting type tracking method 深圳市微视星辰科技有限公司 2025-03-25 — — CN disclosed
US-12233143-B2 Topical compositions containing rose oil and cannabidiol and methods of making and using the same JLABS Beauty LLC (US) 2025-02-25 — — US disclosed
WO-2024046834-A1 ANTIOXIDANT COMPOSITION COMPRISING 5-DEOXYFLAVONOIDS ANALYTICON DISCOVERY GMBH (DE) 2024-03-07 — — WO disclosed
EP-4331564-A1 ANTIOXIDANT COMPOSITION COMPRISING 5-DEOXYFLAVONOIDS Analyticon Discovery GmbH (DE) 2024-03-06 — — EP disclosed
US-20230025960-A1 TOPICAL COMPOSITIONS CONTAINING ROSE OIL AND CANNABIDIOL AND METHODS OF MAKING AND USING THE SAME JLABS Beauty LLC (US) 2023-01-26 — — US disclosed
CN-113425730-B Application of triterpenes and dimer compounds thereof in preparation of drugs for treating diseases mediated by protein tyrosine phosphatase 1B 台州学院 2022-10-21 — — CN disclosed
EP-4069215-A1 TOPICAL COMPOSITIONS CONTAINING ROSE OIL AND CANNABIDIOL AND METHODS OF MAKING AND USING THE SAME Jlabs Beauty LLC (US) 2022-10-12 — — EP disclosed
US-11419800-B2 Topical compositions containing rose oil and cannabidiol and methods of making and using the same JLABS Beauty LLC (US) 2022-08-23 — — US disclosed
CN-114838724-A Sequence waiting type tracking method 深圳市微视星辰科技有限公司 2022-08-02 — — CN disclosed
CN-114558061-A Loquat leaf extract and preparation method and application thereof 浙江大学 2022-05-31 — — CN disclosed
CN-215730456-U NK cell mediated ADCC effect and antibody basic structure model teaching aid 江南大学 2022-02-01 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230025960-A1 TOPICAL COMPOSITIONS CONTAINING ROSE OIL AND CANNABIDIOL AND METHODS OF MAKING AND USING THE SAME RXRG, CNR2, CUTA SLCO2B1 3964/4885PTPN1 3347/4885SYNJ2 613/4885
US-11419800-B2 Topical compositions containing rose oil and cannabidiol and methods of making and using the same RXRG, CNR2, CUTA SLCO2B1 3964/4885PTPN1 3347/4885SYNJ2 613/4885
US-12233143-B2 Topical compositions containing rose oil and cannabidiol and methods of making and using the same RXRG, CNR2, CUTA SLCO2B1 3964/4885PTPN1 3347/4885SYNJ2 613/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback